Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development

Yuyan Bao1, Yanjie Yu2, Bing Hong1

  • 1Pharmaceutical Preparation Section, Sanmen People's Hospital, 15 Taihe Road, Hairun Street, Sanmen County, Zhejiang Province, 317100, P.R.China.

Insights

Hsa_circ_0001947, a circular RNA, suppresses non-small cell lung cancer (NSCLC) development. It acts as a sponge for miR-661, increasing downstream DOK7 expression and inhibiting tumor progression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hsa_circ_0001947's role in non-small cell lung cancer (NSCLC) is unclear.
  • Circular RNAs (circRNAs) are increasingly recognized for their roles in various cancers.

Purpose of the Study:

  • To investigate the function and mechanism of hsa_circ_0001947 in NSCLC.
  • To elucidate the regulatory network involving hsa_circ_0001947, miR-661, and DOK7 in NSCLC.

Main Methods:

  • Database prediction and dual-luciferase reporter assay to confirm targeting relationships.
  • Quantitative real-time polymerase chain reaction (qRT-PCR) to measure gene and miRNA expression.
  • Cell function experiments (viability, proliferation, apoptosis, cell cycle) to assess biological behaviors.

Main Results:

  • Hsa_circ_0001947 was significantly downregulated in NSCLC tissues and cells.
  • Knockdown of hsa_circ_0001947 promoted NSCLC cell viability, proliferation, and S-phase arrest, while suppressing apoptosis.
  • Hsa_circ_0001947 directly targeted miR-661, and miR-661 targeted DOK7, forming a regulatory axis.

Conclusions:

  • Hsa_circ_0001947 functions as a tumor suppressor in NSCLC.
  • The hsa_circ_0001947/miR-661/DOK7 axis plays a crucial role in regulating NSCLC progression.
  • Hsa_circ_0001947 acts as a molecular sponge for miR-661, thereby upregulating DOK7 expression and inhibiting NSCLC development.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.1K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.1K